RNA Sequencing Services Market: Distribution by Type of Sequencing Method (Next Generation Sequencing Method and Other Methods), Application Area (Diagnostic and Research), End User Industry (Academic and Research, Clinics and Hospital, Pharmaceutical Industry and Others) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    September 2022

  • Pages
    196

  • View Count
    671

Example Insights

RNA-Sequencing-Services-Market-Context-thumb RNA-Sequencing-Services-Market-List-of-RNA-Sequencing-Service-Providers-thumb 	RNA-Sequencing-Services-Market-Distribution-by-Type-of-Sample-thumb
RNA-Sequencing-Services-Market-Company-Competitiveness-Analysis-thumb RNA-Sequencing-Services-Market-Patent-Analysis-thumb RNA-Sequencing-Services-Market-Grant-Analysis-thumb
RNA-Sequencing-Services-Market-Porter’s-Five-Forces-Analysis-thumb RNA-Sequencing-Services-Market-Investment-Potential-Analysis-thumb RNA-Sequencing-Services-Market-Distribution-by-Application-Area-thumb

Overview

RNA sequencing was first introduced by Fredrick Sanger in 1977, who used chain termination method, also known sanger sequencing method / first generation sequencing method. It is a rapid method that enables profiling of whole range of RNA expressed by the cell, with increased coverage and resolution. However, the sanger sequencing method costs higher as compared to other methods and has low detection power, which reduces its scalability. Over time, this domain has witnessed several technological advancements, and different methods of RNA sequencing are now being used for differential gene and allele-specific expression, small RNA profiling, and characterization of alternative splicing patterns and system biology. Among various sequencing methods, next generation sequencing (NGS) introduced by Lynx Therapeutics in 2000, has emerged as a preferred choice across the industry. It is a high throughput, parallel genome sequencing technology, which enables whole genome and whole exome sequencing. It enables reduction in overall cost and process time. Despite the various technological advancements in RNA sequencing, there are several existing challenges, including difficulty in sequencing of large genes, shortage of human resources and lack of tools for data manipulation and analysis. In addition, establishment and maintenance of next generation sequencing based facilities require high capital. In order to overcome these challenges and obtain a high-quality output, the outsourcing of RNA sequencing is considered as a preferable option, among other alternatives, by industry players. 

Currently, more than 70 companies offer services related to RNA sequencing. A number of these companies are start-ups that have been established in the past decade. In addition, several stakeholders are engaged in the development of proprietary technologies in order to overcome the errors related to amplification and duplication rates while sequencing. Further, over 340 patents related to RNA sequencing have been recently filed / granted, which demonstrates the innovation and continuous research efforts in this domain. Moreover, over the last few years, grants worth USD 486 million have been awarded by National Institutes of Health to support the ongoing R&D efforts in this domain. Driven by the growing interest of various stakeholders and the wide applicability of this technique, we believe that the RNA sequencing services industry is anticipated to witness noteworthy growth in the foreseen future.

Scope of the Report

The ‘RNA Sequencing Services Market: Distribution by Type of Sequencing Method (Next Generation Sequencing Method, and Other Methods), Application Area (Diagnostic and Research), End User Industry (Academic and Research, Clinics and Hospital, Pharmaceutical Industry and Others), Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035’ report features an extensive study of the current market landscape and future potential of the RNA sequencing services market. The study also includes an in-depth analysis, highlighting the capabilities of RNA sequencing service providers. Amongst other elements, the report features:

  • A general overview of RNA sequencing, along with information on the key steps involved in the process, details on the various types, methods and applications of RNA sequencing, as well as the advantages and limitations associated with RNA sequencing. It further includes details on the different types of RNA sequencing platforms. 
  • A detailed overview of the market landscape of RNA sequencing service providers, based on several relevant parameters, such as their year of establishment, company size (in terms of number of employees), region of headquarters (North America, Europe, Asia-Pacific and MENA). In addition, the chapter features information on the various offerings of such service providers, including type of RNA sequencing service(s), type of platform (Illumina, PacBio, Nanopore and others), turnaround time, type of sample (human, animal, plant, microorganisms and others) and volume of sample.
  • A competitiveness analysis of RNA sequencing service providers, located in North America, Europe, and Asia Pacific and Rest of the World. The analysis compares service providers on the basis of various relevant parameters, such as experience of the company (in terms of number of years since it was established), service portfolio strength (in terms of number of RNA sequencing services offered, number of samples and turnaround time) and platform diversity (in terms of number of RNA sequencing services offered via respective sequencing platforms).
  • Elaborate profiles of key players involved in providing services for RNA sequencing. Each profile features a brief overview of the company, details on its service portfolio and recent developments, along with an informed future outlook.
  • An in-depth analysis of grants awarded to various research institutes for projects related to RNA sequencing, since 2018, based on several relevant parameters, such as year of grant awarded, amount awarded, administering institute center, support period, type of grant application, purpose of grant, activity code, study section, type of organization, emerging focus areas, popular NIH departments, popular recipient organizations (in terms of number of grants and amount awarded), prominent program officers and location of recipient organizations.
  • An insightful analysis of patents filed / granted for RNA sequencing, since 2018, taking into consideration various relevant parameters, such as type of patent, publication year, application year, geographical location, CPC symbols, emerging focus areas, type of applicant, leading players and individual assignees (in terms of number of patents granted / filed in the given time period). In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
  • A qualitative analysis of the five competitive forces, including threats of new entrants, bargaining power of customers, bargaining power of RNA sequencing service providers, threats of substitute services and rivalry among existing competitors under an insightful Porter’s Five Forces framework.
  • A case study on NGS library preparation kits, based on type of platform, amount of sample, turnaround time, storage temperature, type of sequencing(s), kit components, type of sample. In addition, it includes a study on NGS library preparation kit developers, featuring analyses based on their year of establishment, company size and geographical presence.
  • An insightful analysis, highlighting financial attributes (payback period, total cash inflow, and earning potential of platforms) that need to be taken into consideration by various RNA sequencing service providers to facilitate decision making to employ sequencing platform.

One of the key objectives of the report was to estimate the current market size and the future potential associated with the RNA sequencing services market, over the coming 13 years. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of sequencing method (next generation sequencing method and other methods), application area (diagnostic and research), end user industry (academic and research, clinics and hospital, pharmaceutical industry, and others), and key geographical regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the market’s evolution.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

  • Who are the key players engaged in offering RNA sequencing services?
  • What is the average turnaround time of RNA sequencing services currently offered?
  • What is the relative competitiveness of different RNA sequencing service providers?
  • How has the intellectual property landscape of RNA sequencing evolved over the years?
  • Which are the leading funding institutes / centers supporting research related to RNA sequencing?
  • Which type of next generation sequencing kits are being used to collect samples for RNA sequencing? 
  • Which sequencing platform is likely to offer highest earning potential to service providers?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Contents

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4 Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. An Overview of RNA Sequencing
3.2.1. Key Steps Involved in RNA Sequencing
3.2.2. Types of RNA Sequencing
3.2.2.1. Single End Sequencing
3.2.2.2. Paired End Sequencing

3.2.3. Methods of RNA Sequencing
3.2.3.1. First Generation Sequencing
3.2.3.2. Next Generation Sequencing
3.2.3.3. Third Generation Sequencing

3.2.4. Applications of RNA Sequencing
3.2.5. Advantages of RNA Sequencing
3.2.6. Limitations of RNA Sequencing

3.2.7. RNA Sequencing Platforms
3.2.7.1. Illumina Sequencing Platforms
3.2.7.2. Pac Bio Sequencing Platforms
3.2.7.3. Nanopore Sequencing Platforms

3.3. Concluding Remarks

4. RNA SEQUENCING SERVICE PROVIDERS: MARKET OVERVIEW
4.1. Chapter Overview
4.1.1. RNA Sequencing Service Providers
4.1.2. Analysis by Year of Establishment
4.1.3. Analysis by Company Size
4.1.4. Analysis by Location of Headquarters
4.1.5. Analysis by Company Size and Region of Headquarters
4.1.6. Analysis by Type of RNA Sequencing Service(s)
4.1.7. Analysis by Type of Platform
4.1.8. Analysis by Turnaround Time
4.1.9. Analysis by Type of Sample
4.1.10. Analysis by Amount of Sample

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Scope and Methodology
5.4. Company Competitiveness Analysis: RNA Sequencing Service Providers in North America
5.5. Company Competitiveness Analysis: RNA Sequencing Service Providers in Europe
5.6. Company Competitiveness Analysis: RNA Sequencing Service Providers in Asia-Pacific and Rest of the World

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Admera Health
6.2.1. Company Overview
6.2.2. RNA Sequencing Service Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Biogazelle (acquired by CellCarta)
6.3.1. Company Overview
6.3.2. RNA Sequencing Service Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. CD Genomics
6.4.1. Company Overview
6.4.2. RNA Sequencing Service Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. Creative Biogene
6.5.1. Company Overview
6.5.2. RNA Sequencing Service Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. IGA Technology
6.6.1. Company Overview
6.6.2. RNA Sequencing Service Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. LC Sciences
6.7.1. Company Overview
6.7.2. RNA Sequencing Service Portfolio
6.7.3. Recent Developments and Future Outlook

6.8. Lexogen
6.8.1. Company Overview
6.8.2. RNA Sequencing Service Portfolio
6.8.3. Recent Developments and Future Outlook

6.9. Novogene
6.9.1. Company Overview
6.9.2. RNA Sequencing Service Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Otogenetics
6.10.1. Company Overview
6.10.2. RNA Sequencing Service Portfolio
6.10.3. Recent Developments and Future Outlook

6.11. Yaazh Xenomic
6.11.1. Company Overview
6.11.2. RNA Sequencing Service Portfolio
6.11.3. Recent Developments and Future Outlook

7. ACADEMIC GRANT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Analysis by Year of Grant Award
7.3.1. Analysis by Amount Awarded
7.3.2. Analysis by Administering Institute Centre
7.3.3. Analysis by Support Period
7.3.4. Analysis by Administering Institute Centre and Support Period
7.3.5. Analysis by Type of Grant Application
7.3.6. Analysis by Purpose of Grant
7.3.7. Analysis by Purpose of Grant and Amount Awarded
7.3.8. Analysis by Activity Code
7.3.9. Analysis by Study Section Involved
7.3.10. Analysis by Type of Organization
7.3.11. Word Cloud: Emerging Focus Areas
7.3.12. Most Popular Departments: Analysis by Number of Grants
7.3.13. Prominent Program Officers: Analysis by Number of Grants
7.3.14. Popular Recipient Organizations: Analysis by Number of Grants
7.3.15. Popular Recipient Organizations: Analysis by Amount Awarded
7.3.16. Analysis of Recipient Organizations located in the US

8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. RNA Sequencing: Patent Analysis
8.3.1. Analysis by Publication Year
8.3.2. Analysis by Application Year
8.3.3. Analysis by Annual Number of Granted Patents and Patent Applications
8.3.4. Analysis by Geography
8.3.5. Analysis by CPC Symbols
8.3.6. Analysis by Focus Area
8.3.7. Analysis by Type of Applicant
8.3.8. Leading Players: Analysis by Number of Patents
8.3.9. Leading Individual Assignees: Analysis by Number of Patents

8.4. RNA Sequencing: Patent Benchmarking Analysis
8.4.1. Analysis by Patent Characteristics

8.5. RNA sequencing: Patent Valuation Analysis
8.6. Leading Patents: Analysis by Number of Citations

9. PORTER’S FIVE FORCES ANALYSIS
9.1. Chapter Overview
9.2. Methodology and Assumptions
9.3. Key Parameters
9.3.1. Threats of New Entrants
9.3.2. Power of Customers
9.3.3. Power of RNA Sequencing Service Providers
9.3.4. Threats of Substitute Services
9.3.5. Rivalry Among Existing Competitors

9.4. Concluding Remarks

10. CASE STUDY: NGS LIBRARY PREPARATION KITS
10.1. Chapter Overview
10.2. NGS Library Preparation Kits: Overall Market Landscape
10.2.1. Analysis by Type of Platform
10.2.2. Analysis by Amount of Sample
10.2.3. Analysis by Turnaround Time
10.2.4. Analysis by Storage Temperature
10.2.5. Analysis by Type of Sequencing
10.2.6. Analysis by Kit Components
10.2.7. Analysis by Type of Sample

10.3. NGS Library Preparation Kits: Developer Landscape
10.3.1. Analysis by Year of Establishment
10.3.2. Analysis by Company Size
10.3.3. Analysis by Region of Headquarters

11. INVESTMENT POTENTIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Profit Potential of Commonly used RNA Sequencing Platforms
11.2.1. iSeq: Likely Profit Potential
11.2.2. MiSeq: Likely Profit Potential
11.2.3. NextSeq 550 Series: Likely Profit Potential
11.2.4. NextSeq 1000: Likely Profit Potential
11.2.5. NextSeq 1000: Likely Profit Potential
11.2.6. Sequel: Likely Profit Potential
11.2.7. Sequel II: Likely Profit Potential
11.2.8. Sequel IIe: Likely Profit Potential
11.4. Payback Evaluation Matrix

11.3. Conclusion

12. MARKET SIZING AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global RNA Sequencing Services Market, 2022-2035
12.3.1. RNA Sequencing Services Market, 2022-2035: Distribution by Type of Sequencing Method
12.3.1.1. RNA Sequencing Services Market for Next Generation Sequencing Methods, 2022-2035
12.3.1.2. RNA Sequencing Services Market for Other Methods, 2022-2035

12.3.2. RNA Sequencing Services Market, 2022-2035: Distribution by Type of Application Area
12.3.2.1. RNA Sequencing Services Market for Research Purposes, 2022-2035
12.3.2.2. RNA Sequencing Services Market for Diagnostic Purposes, 2022-2035

12.3.3. RNA Sequencing Services Market, 2022-2035: Distribution by Type of End User Industry
12.3.3.1. RNA Sequencing Services Market for Academic and Research Industry, 2022-2035
12.3.3.2. RNA Sequencing Services Market for Clinics and Hospitals, 2022-2035
12.3.3.3. RNA Sequencing Services Market for Pharmaceutical Industry, 2022-2035
12.3.3.4. RNA Sequencing Services Market for Other Users, 2022-2035

12.3.4. RNA Sequencing Services Market, 2022-2035: Distribution by Key Geographical Regions
12.3.4.1. RNA Sequencing Services Market in North America, 2022-2035
12.3.4.2. RNA Sequencing Services Market in Europe, 2022-2035
12.3.4.3. RNA Sequencing Services Market in Asia-Pacific, 2022-2035
12.3.4.4. RNA Sequencing Services Market in Latin America, 2022-2035
12.3.4.5. RNA Sequencing Services Market in Middle East and North Africa, 2022-2035

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Key Steps Involved in RNA Sequencing
Figure 4.1 RNA Sequencing Service Providers: Distribution by Year of Establishment
Figure 4.2 RNA Sequencing Service Providers: Distribution by Company Size
Figure 4.3 RNA Sequencing Service Providers: Distribution by Location of Headquarters (Region Wise)
Figure 4.4 RNA Sequencing Service Providers: Distribution by Location of Headquarters (Country Wise)
Figure 4.5 RNA Sequencing Service Providers: Distribution by Company Size and Region of Headquarters
Figure 4.6 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Service(s) Offered
Figure 4.7 RNA Sequencing Service Providers: Distribution by Platform
Figure 4.8 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Service(s) and Type of Platform
Figure 4.9 RNA Sequencing Service Providers: Distribution by Turnaround Time
Figure 4.10 RNA Sequencing Service Providers: Distribution by Type of Sample
Figure 4.11 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Services(s) and Type of Sample
Figure 4.12 RNA Sequencing Service Providers: Distribution by Amount of Sample (in mg)
Figure 4.13 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Services(s) and Amount of Sample
Figure 5.1 Company Competitiveness Analysis: RNA Sequencing Service Providers in North America
Figure 5.2 Company Competitiveness Analysis: RNA Sequencing Service Providers in Europe
Figure 5.3 Company Competitiveness Analysis: RNA Sequencing Service Providers in Asia-Pacific
Figure 7.1 Grant Analysis: Cumulative Year-Wise Trend, 2017-2022
Figure 7.2 Grant Analysis: Distribution by Amount Awarded (USD Million)
Figure 7.3 Grant Analysis: Distribution by Administering Institute Centre
Figure 7.4 Grant Analysis: Distribution by Support Period
Figure 7.5 Grant Analysis: Distribution by Administering Institute Centre and Support Period
Figure 7.6 Grant Analysis: Distribution by Type of Grant Application
Figure 7.7 Grant Analysis: Distribution by Purpose of Grant Award
Figure 7.8 Grant Analysis: Distribution of Amount Awarded by Purpose of Grant (USD Million)
Figure 7.9 Grant Analysis: Distribution by Activity Code
Figure 7.10 Grant Analysis: Distribution by Study Section Involved
Figure 7.11 Grant Analysis: Distribution by Type of Organization
Figure 7.12 Most Popular Departments: Distribution by Number of Grants
Figure 7.13 Word Cloud: Emerging Focus Areas
Figure 7.14 Prominent Program Officers: Distribution by Number of Grants
Figure 7.15 Popular Recipient Organizations: Distribution by Number of Grants
Figure 7.16 Popular Recipient Organization: Distribution by Amount Awarded (USD Million)
Figure 7.17 Grant Analysis: Distribution of Recipient Organizations located in US
Figure 8.1 Patent Analysis: Distribution by Type of Patent
Figure 8.2 Patent Analysis: Cumulative Distribution by Publication Year, 2018-2022
Figure 8.3 Patent Analysis: Cumulative Distribution by Application Year, Pre-2016 - 2022
Figure 8.4 Patent Analysis: Distribution by Annual Number of Granted Patents and Patent Applications, 2018-2022
Figure 8.5 Patent Analysis: Distribution by Geography
Figure 8.6 Patent Analysis: Distribution by CPC Symbols
Figure 8.7 Word Cloud: Emerging Focus Areas
Figure 8.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Figure 8.9 Leading Industry Players: Distribution by Number of Patents
Figure 8.10 Leading Non-Industry Players: Distribution by Number of Patents
Figure 8.11 Patent Analysis: Leading Individual Assignees
Figure 8.12 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Symbols)
Figure 8.13 Patent Analysis: Distribution by Patent Age
Figure 8.14 Patent Valuation Analysis
Figure 9.1 Porter’s Five Forces: Key Parameters
Figure 9.2 Porter’s Five Forces: Harvey Ball Analysis
Figure 10.1 NGS Library Preparation Kits: Distribution by Type of Platform
Figure 10.2 NGS Library Preparation Kits: Distribution by Amount of Sample
Figure 10.3 NGS Library Preparation Kits: Distribution by Turnaround Time
Figure 10.4 NGS Library Preparation Kits: Distribution by Storage Temperature
Figure 10.5 NGS Library Preparation Kits: Distribution by Type of Sequencing
Figure 10.6 NGS Library Preparation Kits: Distribution by Kit Components
Figure 10.7 NGS Library Preparation Kits: Distribution by Type of Sample
Figure 10.8 NGS Library Preparation Kit Providers: Distribution by Year of Establishment
Figure 10.9 NGS Library Preparation Kit Providers: Distribution by Company Size
Figure 10.10 NGS Library Preparation Kit Providers: Distribution by Location of Headquarters
Figure 11.1 Likely Profit Potential of iSeq platform
Figure 11.2 Likely Profit Potential of MiSeq platform
Figure 11.3 Likely Profit Potential of NextSeq 550 Series platform
Figure 11.4 Likely Profit Potential of NextSeq 1000 platform
Figure 11.5 Likely Profit Potential of NextSeq 2000 platform
Figure 11.6 Likely Profit Potential of Sequel platform
Figure 11.7 Likely Profit Potential of Sequel II platform
Figure 11.8 Likely Profit Potential of Sequel IIe platform
Figure 11.9 Payback Evaluation Matrix
Figure 12.1 Global RNA Sequencing Services Market, 2022-2035 (USD Billion)
Figure 12.2 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of Sequencing Method
Figure 12.3 RNA Sequencing Services Market for Next Generation Sequencing Method, 2022-2035 (USD Billion)
Figure 12.4 RNA Sequencing Services Market for Other Method, 2022-2035 (USD Billion)
Figure 12.5 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of Application
Figure 12.6 RNA Sequencing Services Market for Research Purposes, 2022-2035 (USD Billion)
Figure 12.7 RNA Sequencing Services Market for Diagnostic Purposes, 2022-2035 (USD Billion)
Figure 12.8 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of End User
Figure 12.9 RNA Sequencing Services Market for Academic and Research Industry, 2022-2035 (USD Billion)
Figure 12.10 RNA Sequencing Services Market for Clinics and Hospitals, 2022-2035 (USD Billion)
Figure 12.11 RNA Sequencing Services Market for Pharmaceutical Industry, 2022-2035 (USD Billion)
Figure 12.12 RNA Sequencing Services Market for Other Users, 2022-2035 (USD Billion)
Figure 12.13 RNA Sequencing Services Market, 2022 and 2035: Distribution by Key Geographical Regions
Figure 12.14 RNA Sequencing Services Market in North America, 2022-2035 (USD Billion)
Figure 12.15 RNA Sequencing Services Market in Europe, 2022-2035 (USD Billion)
Figure 12.16 RNA Sequencing Services Market in Asia-Pacific, 2022-2035 (USD Billion)
Figure 12.17 RNA Sequencing Services Market in Latin America, 2022-2035 (USD Billion)
Figure 12.18 RNA Sequencing Services Market in Middle East and North Africa, 2022-2035 (USD Billion)

List Of Tables

Table 4.1 List of RNA Sequencing Service Providers
Table 4.2 RNA Sequencing Service Providers: Information on Type of RNA Sequencing Service(s), Type of Platform, and Turnaround time
Table 4.3 RNA Sequencing Service Providers: Information on Type of RNA Sequencing Service(s), Type of Sample, and Amount of Sample
Table 6.1 Admera Health: Company Overview
Table 6.2 Admera Health: RNA Sequencing Service Portfolio
Table 6.3 Biogazelle: Company Overview
Table 6.4 Biogazelle: RNA Sequencing Service Portfolio
Table 6.5 CD Genomics: Company Overview
Table 6.6 CD Genomics: RNA Sequencing Service Portfolio
Table 6.7 Creative Biogene: Company Overview
Table 6.8 Creative Biogene: RNA Sequencing Service Portfolio
Table 6.9 IGA Technology: Company Overview
Table 6.10 IGA Technology: RNA Sequencing Service Portfolio
Table 6.11 LC Sciences: Company Overview
Table 6.12 LC Sciences: RNA Sequencing Service Portfolio
Table 6.13 Lexogen: Company Overview
Table 6.14 Lexogen: RNA Sequencing Service Portfolio
Table 6.15 Lexogen: Recent Developments and Future Outlook
Table 6.16 Novogene: Company Overview
Table 6.17 Novogene: RNA Sequencing Service Portfolio
Table 6.18 Novogene: Recent Developments and Future Outlook
Table 6.19 Otogenetics: Company Overview
Table 6.20 Otogenetics: RNA Sequencing Service Portfolio
Table 6.21 Yaazh Xenomic: Company Overview
Table 6.22 Yaazh Xenomics: RNA Sequencing Service Portfolio
Table 8.1 Patent Analysis: Most Popular CPC Symbols
Table 8.2 Patent Analysis: List of Top CPC Symbols
Table 8.3 Patent Analysis: Summary of Benchmarking Analysis
Table 8.4 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 8.5 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 8.6 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 11.1 Investment Analysis and Likely Profit Potential: Cost Consideration
Table 11.2 Investment Analysis and Likely Profit Potential: Revenue Consideration
Table 11.3 Investment Analysis and Likely Profit Potential: Minimum Sales Required for iSeq 100
Table 11.4 Investment Analysis and Likely Profit Potential: Minimum Sales Required for MiSeq
Table 11.5 Investment Analysis and Likely Profit Potential: Minimum Sales Required for NextSeq 550
Table 11.6 Investment Analysis and Likely Profit Potential: Minimum Sales Required for NextSeq 1000
Table 11.7 Investment Analysis and Likely Profit Potential: Minimum Sales Required for NextSeq 2000
Table 11.8 Investment Analysis and Likely Profit Potential: Minimum Sales Required for Sequel
Table 11.9 Investment Analysis and Likely Profit Potential: Minimum Sales Required for Sequel II
Table 11.10 Investment Analysis and Likely Profit Potential: Minimum Sales Required for Sequel IIe
Table 11.11 Investment Analysis and Likely Profit Potential: Payback Evaluation Matrix
Table 15.1 RNA Sequencing Service Providers: Distribution by Year of Establishment
Table 15.2 RNA Sequencing Service Providers: Distribution by Company Size
Table 15.3 RNA Sequencing Service Providers: Distribution by Location of Headquarters (Region-wise)
Table 15.4 RNA Sequencing Service Providers: Distribution by Location of Headquarters (Country-wise)
Table 15.5 RNA Sequencing Service Providers: Distribution by Company Size and Region of Headquarters
Table 15.6 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Service(s)
Table 15.7 RNA Sequencing Service Providers: Distribution by Turnaround Time
Table 15.8 RNA Sequencing Service Providers: Distribution by Type of Sample
Table 15.9 RNA Sequencing Service Providers: Distribution by Amount of Sample (in mg)
Table 15.10 Grant Analysis: Cumulative Year-Wise Trend, 2018-2022
Table 15.11 Grant Analysis: Distribution by Amount Awarded (USD Million)
Table 15.12 Grant Analysis: Distribution by Administering Institute Centre
Table 15.13 Grant Analysis: Distribution by Support Period
Table 15.14 Grant Analysis: Distribution by Type of Grant Application
Table 15.15 Grant Analysis: Distribution of Amount Awarded by Purpose of Grant Award (USD Million)
Table 15.16 Grant Analysis: Distribution by Purpose of Grant Award
Table 15.17 Grant Analysis: Distribution by Activity Code
Table 15.18 Grant Analysis: Distribution by Study Section Involved
Table 15.19 Grant Analysis: Distribution by Type of Organization
Table 15.20 Most Popular Departments: Distribution by Number of Grants
Table 15.21 Prominent Program Officers: Distribution by Number of Grants
Table 15.22 Popular Recipient Organizations: Distribution by Number of Grants
Table 15.23 Popular Recipient Organizations: Distribution by Amount of Grant
Table 15.24 Grant Analysis: Distribution of Recipient Organizations located in US
Table 15.25 Patent Analysis: Distribution by Type of Patent
Table 15.26 Patent Analysis: Cumulative Distribution by Publication Year, 2018-2022
Table 15.27 Patent Analysis: Cumulative Distribution by Application Year, Pre-2016 - 2022
Table 15.28 Patent Analysis: Cumulative Distribution by Annual Number of Granted Patents and Patents Applications, 2018-2022
Table 15.29 Patent Analysis: Distribution by Geography
Table 15.30 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Table 15.31 Leading Industry Players: Distribution by Number of Patents
Table 15.32 Leading Non-Industry Players: Distribution by Number of Patents
Table 15.33 Patent Analysis: Leading Individual Assignees
Table 15.34 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 15.35 NGS Library Preparation Kits: Distribution by Type of Platform
Table 15.36 NGS Library Preparation Kits: Distribution by Amount of Sample
Table 15.37 NGS Library Preparation Kits: Distribution by Turnaround Time
Table 15.38 NGS Library Preparation Kits: Distribution by Storage Temperature
Table 15.39 NGS Library Preparation Kits: Distribution by Type of Sequencing
Table 15.40 NGS Library Preparation Kits: Distribution by Kit Components
Table 15.41 NGS Library Preparation Kits: Distribution by Type of Sample
Table 15.42 NGS Library Preparation Kits Providers: Distribution by Year of Establishment
Table 15.43 NGS Library Preparation Kits Providers: Distribution by Company Size
Table 15.44 NGS Library Preparation Kits Providers: Distribution by Location of Headquarters
Table 15.45 Likely Profit Potential of iSeq platform
Table 15.46 Likely Profit Potential of MiSeq platform
Table 15.47 Likely Profit Potential of NextSeq 550 Series platform
Table 15.48 Likely Profit Potential of NextSeq 1000 platform
Table 15.49 Likely Profit Potential of NextSeq 2000 platform
Table 15.50 Likely Profit Potential of Sequel platform
Table 15.51 Likely Profit Potential of Sequel II platform
Table 15.52 Likely Profit Potential of Sequel IIe platform
Table 15.53 Global RNA Sequencing Services Market, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.54 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of Sequencing Method
Table 15.55 RNA Sequencing Services Market for Next Generation Sequencing Method, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.56 RNA Sequencing Services Market for Other Methods, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.57 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of Application
Table 15.58 RNA Sequencing Services Market for Research Purposes, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.59 RNA Sequencing Services Market for Diagnostic Purposes, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.60 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of End User
Table 15.61 RNA Sequencing Services Market for Academic and Research Industry, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.62 RNA Sequencing Services Market for Clinics and Hospitals, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.63 RNA Sequencing Services Market for Pharmaceutical Industry, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.64 RNA Sequencing Services Market for Other Users, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.65 RNA Sequencing Services Market, 2022 and 2035: Distribution by Key Geographical Regions
Table 15.66 RNA Sequencing Services Market in North America, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.67 RNA Sequencing Services Market in Europe, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.68 RNA Sequencing Services Market in Asia-Pacific, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.69 RNA Sequencing Services Market in Latin America, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.70 RNA Sequencing Services Market in Middle East and North Africa, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Bllion)

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report:

  1. Abclonal
  2. Active Motif
  3. Admera Health
  4. Agendia
  5. Agilent Technologies
  6. AgriGenome Labs
  7. Allen Institute
  8. Almac
  9. Applied Biological Materials
  10. Arraystar
  11. Australian Genome Research Facility (AGRF)
  12. Back Bay Life Science Advisors 
  13. BaseClear
  14. BGI
  15. Bioarray Genetics
  16. BioCat
  17. BioChain
  18. BioDynami
  19. Biogazelle (acquired by CellCarta)
  20. Biokart India 
  21. Bioneer
  22. Bio-Rad
  23. Bioserve Biotechnologies (a subsidiary of Reprocell Company)
  24. Brigham and Women's Hospital
  25. C2i Genomics
  26. CD Genomics
  27. CeGaT
  28. Celemics
  29. Cellecta
  30. Clevergene Biocorp
  31. Columbia University Health Sciences
  32. Creative Biogene
  33. Creative Biolabs
  34. Creative BioMart
  35. CureVac
  36. DiaCarta
  37. Diagenode (acquired by Hologic)
  38. Diagnomics
  39. DNA Link
  40. DNAVision
  41. Duke Center for Genomic and Computational Biology
  42. Eclipse Bioinnovations
  43. Enzo Life Sciences
  44. Eremid Research Services
  45. Eurofins Genomics
  46. Fasteris
  47. Firalis
  48. Fluidigm
  49. Frontage Laboratories
  50. Garvan Institute of Medical Research
  51. GB HealthWatch
  52. GCC Biotech
  53. GENEWIZ (acquired by Azenta Life Sciences)
  54. Genome Quebec
  55. GenomeScan
  56. Genome Technology Access Center (a part of Washington University)
  57. Genomix4Life
  58. Genotypic Technology
  59. GenXPro
  60. Grail
  61. Harvard Medical School
  62. Icahn School of Medicine
  63. IGA Technology Services
  64. Illumina
  65. IntegraGen (acquired by OncoDNA)
  66. Integrated DNA Technologies
  67. Isogen Life Science
  68. Johns Hopkins University
  69. Koninklijke Philips
  70. LC Sciences
  71. Lexogen
  72. Loop Genomics
  73. Macrogen
  74. Massachusetts General Hospital
  75. Massachusetts Institute of Technology (MIT)
  76. Mayo Clinic
  77. MedGenome
  78. Memorial Sloan Kettering Cancer Center
  79. Messenger Biopharma
  80. MGI
  81. Microsynth
  82. Molecular Research (MR DNA)
  83. myGenomics
  84. New England Biolabs (NEB)
  85. Norgen Biotek
  86. Novogene
  87. Nucleome Informatics
  88. Omega Bioservices
  89. Otogenetics
  90. Oxford Nanopore Technologies
  91. Pacific Biosciences (PacBio)
  92. PerkinElmer
  93. PhalanxBio (a subsidiary of Phalanx Biotech)
  94. Psomagen
  95. Q2 Solutions
  96. QIAGEN
  97. Quick Biology
  98. RealSeq Biosciences
  99. RefGen Biotechnology
  100. RNA Society
  101. Roche
  102. SeqMatic
  103. Source BioScience
  104. SRM Institute of Science and Technology
  105. Stanford University
  106. Swift Biosciences (acquired by Integrated DNA Technologies)
  107. System Biosciences (SBI)
  108. Takara Bio
  109. TAmiRNA
  110. Tecan
  111. Thermo Fisher Scientific
  112. TIANGEN Biotech
  113. TriLink BioTechnologies
  114. Ultima Genomics
  115. University of California
  116. University of Pennsylvania
  117. Vazyme Biotech
  118. Xcelris Genomics
  119. Yaazh Xenomics
  120. Yale University
  121. YouSeq
  122. Zymo Research

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 8) n a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com